DITTO Daily

Cover Block

Metric	Value
Name	DITTO Daily
Tagline	Science-led direct-to-consumer supplements for menstrual health and cycle symptom relief.
Headquarters	London, UK
Founded	2024
Stage	Pre-Seed
Business Model	Direct-to-Consumer (DTC)
Industry	Healthtech
Technology	Biotech / Life Sciences
Geography	Western Europe
Growth Profile	Venture Scale
Founding Team	Solo Founder
Funding Label	Pre-seed
Total Disclosed	~$1.72 million (approx. £1.35 million) [Raising.fi, August 2025]

Links

• Website: https://dittodaily.com
• LinkedIn: https://uk.linkedin.com/in/alice-van-der-schoot-957358371
• Trustpilot: https://uk.trustpilot.com/review/dittodaily.com

What an Investor Needs First

DITTO Daily is a London-based direct-to-consumer startup that has secured a £1.35 million pre-seed round to sell science-led supplements specifically for menstrual health [Raising.fi, August 2025]. The company was founded in 2024 by Alice van der Schoot, a PhD nutrition scientist whose academic research informs the product formulation [BeautyMatter, October 2025]. Its flagship Cycle Supplement is designed to alleviate common symptoms like cramps, mood swings, and fatigue, with a trial showing 88% of participants experienced a reduction in overall symptom severity [BusinessCloud].

The business model is pure DTC, selling subscriptions and one-off purchases through its own website [dittodaily.com]. With the pre-seed capital led by Eka Ventures, the company is funded to scale its branding and direct sales efforts [Raising.fi, August 2025]. Over the next 12 to 18 months, the key watchpoints will be the efficiency of its customer acquisition funnel, any expansion into retail or healthcare partnerships, and the translation of its strong clinical signal into sustained revenue growth and brand loyalty.

Data Accuracy: GREEN -- Core facts (founding, funding, founder background, product claims) corroborated by multiple independent sources.

Taxonomy Snapshot

Axis	Classification
Stage	Pre-Seed
Business Model	Direct-to-Consumer (DTC)
Industry / Vertical	Healthtech
Technology Type	Biotech / Life Sciences
Geography	Western Europe
Growth Profile	Venture Scale
Founding Team	Solo Founder
Funding	Pre-seed (total disclosed ~$1,720,000)

Inside the Company

Alice van der Schoot founded DITTO Daily in 2024, a direct-to-consumer supplement brand that emerged from her concurrent PhD research in nutritional sciences at King's College London [King's College London]. The company's formation was formalized in April of that year, with van der Schoot listed as the sole director of the UK-registered legal entity DITTO DAILY LTD [Companies House, April 2024].

The company's first significant milestone was the development and launch of its flagship Cycle Supplement, a daily formula designed to alleviate cramps, mood swings, and fatigue [Nutraceutical Business Review]. This was followed by the publication of clinical trial results in 2025, which reported that 88% of participants experienced a reduction in overall symptom severity [BusinessCloud].

A key operational milestone was the closing of a £1.35 million (approximately $1.72 million) pre-seed funding round in August 2025, led by London-based venture firm Eka Ventures [Raising.fi, August 2025].

Data Accuracy: GREEN -- Confirmed by Companies House, Raising.fi, and multiple publisher reports.

Under the Hood

DITTO Daily's commercial proposition is anchored in a single, research-intensive product. The company sells its flagship Cycle Supplement directly to consumers, a daily capsule formulated to target core hormonal symptoms including cramps, mood swings, fatigue, bloating, and acne [Nutraceutical Business Review]. The product's primary differentiator is its foundation in clinical research, a claim supported by trial data showing 88% of participants experienced a reduction in overall symptom severity [BusinessCloud]. A separate study indicated 88% of participants agreed they had fewer mood changes by the third cycle of use [Citruslabs].

The underlying technology is framed around bioavailability. The supplement employs an advanced beadlet delivery system, which the company states is designed for enhanced absorption of its active ingredients [Nutraceutical Business Review]. The formulation is described as "science-led" and "PhD-designed," with founder Alice van der Schoot's nutrition science background cited as the source of its evidence-based ingredient selection [Nordic9]. The commercial model is purely direct-to-consumer, with the product available for one-time purchase or via subscription through the company's website [dittodaily.com].

Data Accuracy: GREEN -- Product claims and trial results are corroborated by multiple independent publications and the company's own site.

Market Research

Menstrual health is emerging as a distinct and investable category, propelled by a confluence of consumer demand, scientific inquiry, and a broader cultural shift towards personalized wellness.

Metric	Value
Global Women's Health Market 2022	$41B
Projected Women's Health Market 2027	$58B
Global Vitamins & Supplements Market 2023	$177B

Data Accuracy: YELLOW -- Market sizing figures are drawn from third-party analyst reports (Meticulous Research, Grand View Research) which provide a credible analog but do not size the specific menstrual supplement niche.

Competition and Substitutes

DITTO Daily enters a market defined by broad wellness brands and a growing number of specialized femtech challengers, positioning itself as the most research-intensive option for menstrual symptom relief.

Company	Positioning	Stage / Funding	Notable Differentiator
DITTO Daily	Science-led DTC supplements for menstrual cycle symptom relief.	Pre-seed, £1.35M (2025).	PhD-designed formulation with published clinical trial results (88% symptom reduction).
Perelel Health	OB/GYN-founded vitamin packs tailored to life stages.	Seed, $9M (2022).	Strong medical-founder credibility and a life-stage segmentation model.

Data Accuracy: YELLOW -- The subject's position and single named competitor are confirmed. The broader competitive analysis is inferred from market structure.

Opportunity

If DITTO Daily successfully translates its early clinical validation into a trusted, category-defining brand, it could capture a meaningful share of the global menstrual health supplement market.

Scenario	What happens	Catalyst	Why it's plausible
Retail Expansion	DITTO becomes the go-to menstrual health brand on pharmacy shelves.	A flagship partnership with a major retailer.	The brand's science-led narrative creates pull-through demand.
B2B2C via Corporate Wellness	The supplement is offered as a benefit through corporate wellness programs.	A pilot program with a forward-thinking employer.	DITTO's clinical data provides the evidence base required for B2B procurement.
Product-Led Expansion	The company launches new products targeting adjacent hormonal health issues.	The successful launch of a second, clinically-tested product line.	The founder's research provides a research foundation for expansion.

Data Accuracy: YELLOW -- Clinical claims are well-cited; social media follower count is from a single source. Market comparable is from public reporting.

Sources

1. [Raising.fi, August 2025] DITTO Daily - Company Profile | https://raising.fi/company/dittodaily
2. [BeautyMatter, October 2025] DITTO Daily secures £1.35 Million Pre-Seed Funding | https://beautymatter.com/articles/ditto-daily-secures-pre-seed-funding
3. [BusinessCloud] DITTO Daily trial results coverage
4. [dittodaily.com] DITTO Daily Official Website | https://dittodaily.com
5. [King's College London] Alice van der Schoot PhD profile
6. [Companies House, April 2024] DITTO DAILY LTD - Officers | https://find-and-update.company-information.service.gov.uk/company/15657558/officers
7. [Nutraceutical Business Review] DITTO Daily product feature
8. [Citruslabs] DITTO Daily clinical trial results
9. [Nordic9] DITTO Daily company information | https://nordic9.com/companies/ditto-daily/
10. [Women Entrepreneurs Review] Women-Led Startup DITTO Daily Rises 1.35m Pound In Pre-Seed Round | https://www.womenentrepreneursreview.com/news/women-led-startup-ditto-daily-rises-135m-pound-in-pre-seed-round-headed-by-eka-ventures-nwid-7216.html
11. [The Endo Belly Coach] EP.372/ Evidence-Based Nutrients for PMS, PMDD, Endo Pain and ADHD with Alice van der Schoot | https://www.theendobellycoach.com/podcast/evidence-based-nutrients-for-endo-ditto
12. [Meticulous Research, 2022] Women's Health Market Size Report
13. [Grand View Research, 2023] Vitamins & Dietary Supplements Market Size Report
14. [Rock Health, 2022] 2021 Year-End Digital Health Funding Report
15. [Crunchbase] Perelel Health - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/perelel-health
16. [Forbes, 2021] Ritual Valued at $1 Billion | https://www.forbes.com/sites/alexkonrad/2021/10/05/ritual-vitamin-startup-raises-25-million/?sh=6c1e5c3a4f6d